BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Authors
»
Kim Coghill
Articles by Kim Coghill
Triad, Schering-Plough Align To Discover Antifungal Compounds
Dec. 11, 2002
By
Kim Coghill
Triad, Schering-Plough Align To Discover Antifungal Compounds
Dec. 11, 2002
By
Kim Coghill
Millennium's Phase II Velcade Data Shows 35 Percent Response
Dec. 10, 2002
By
Kim Coghill
Millennium's Phase II Velcade Data Shows 35 Percent Response
Dec. 10, 2002
By
Kim Coghill
BIO Revises Corn Policy, Further Revision Possible
Dec. 9, 2002
By
Kim Coghill
BIO Revises Corn Policy, Further Revision Possible
Dec. 9, 2002
By
Kim Coghill
Dendreon Tightens Focus Of Phase III Provenge Trial
Dec. 6, 2002
By
Kim Coghill
Millennium Juggles Management, Plans Velcade NDA After Phase II
Dec. 6, 2002
By
Kim Coghill
Corixa, Kirin To Collaborate On Cancer Vaccine Program
Dec. 6, 2002
By
Kim Coghill
Millennium Juggles Management, Plans Velcade NDA After Phase II
Dec. 6, 2002
By
Kim Coghill
Previous
1
2
…
94
95
96
97
98
99
100
101
102
…
142
143
Next